TELETRADER News
5/25, 2:06 PM (Source: TeleTrader)
more TeleTrader news

Moderna's COVID vaccine 100% effective in 12-17s

Moderna Inc. announced on Tuesday that its COVID-19 vaccine has been proved to be 100% effective among teens aged between 12 and 17 years, adding it plans to seek approval from the Food and Drug Administration in early June.

"We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents. It is particularly exciting to see that the Moderna COVID-19 vaccine can prevent SARS-CoV-2 infection. We will submit these results to the U.S. FDA and regulators globally in early June and request authorization. We remain committed to doing our part to help end the COVID-19 pandemic," CEO Stephane Bancel said.

The American company added that no significant safety concerns were identified during the trial. Moderna's jab is the second one that could get approved by the United States health authority as the Pfizer/BioNTech shot has already been authorized for emergency use among children.

Breaking the News / ND